Variant report
Variant | esv3376323 |
---|---|
Chromosome Location | chr9:2540959-2541257 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-VLDLR-1 | chr9:2541097-2541214 | XLOC_007267 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CCNE2 | miRNA target sites |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139775562 | chr9:2540972-2540973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs633757 | chr9:2540980-2540981 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs829970 | chr9:2541018-2541019 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs555052691 | chr9:2541052-2541053 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9695842 | chr9:2541083-2541084 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs9695107 | chr9:2541088-2541089 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs559137422 | chr9:2541097-2541098 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs532119283 | chr9:2541109-2541110 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs185731646 | chr9:2541121-2541122 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs386731721 | chr9:2541127-2541128 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs829972 | chr9:2541139-2541140 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs145198217 | chr9:2541159-2541160 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs147187356 | chr9:2541173-2541174 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs536648332 | chr9:2541183-2541184 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs140543803 | chr9:2541205-2541206 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs199826173 | chr9:2541230-2541231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs398113152 | chr9:2541234-2541235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77194606 | chr9:2541237-2541238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs199898559 | chr9:2541240-2541241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7852063 | chr9:2541242-2541243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 16715143 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 21373258 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Schizophrenia | 23813976 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:2503400-2541000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr9:2506600-2559200 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr9:2522200-2542600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr9:2529200-2549800 | Weak transcription | Aorta | Aorta |
5 | chr9:2533000-2541800 | Weak transcription | Brain Substantia Nigra | brain |
6 | chr9:2537200-2556000 | Weak transcription | Left Ventricle | heart |
7 | chr9:2538600-2549800 | Weak transcription | Ovary | ovary |
8 | chr9:2539600-2541200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr9:2540000-2541000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |